Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,117 | 28,647 | 43,068 | 16,516 | 19,269 |
| Marketable Securities | 18,667 | 17,984 | 12,419 | 24,117 | 31,410 |
| Receivables | 83,693 | 89,587 | 81,047 | 79,931 | 78,736 |
| Inventories | 92,539 | 92,746 | 70,025 | 72,965 | 56,932 |
| TOTAL | $228,984 | $238,066 | $229,400 | $210,923 | $212,841 |
| Non-Current Assets | |||||
| PPE Net | 12,025 | 12,403 | 12,960 | 13,683 | 14,537 |
| Other Non-Current Assets | 5,207 | 5,408 | 6,590 | 7,484 | 8,374 |
| TOTAL | $17,232 | $17,811 | $19,550 | $21,167 | $22,911 |
| Total Assets | $246,216 | $255,877 | $248,950 | $232,090 | $235,752 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,970 | 8,994 | 12,017 | 12,037 | 12,333 |
| Accrued Expenses | 31,556 | 35,867 | 28,411 | 23,606 | 26,511 |
| TOTAL | $90,516 | $96,098 | $89,708 | $258,601 | $88,557 |
| Non-Current Liabilities | |||||
| Long Term Debt | 108,307 | 107,899 | 107,487 | N/A | 25,213 |
| Other Non-Current Liabilities | 38,256 | 37,547 | 36,870 | 747 | 150,435 |
| TOTAL | $146,563 | $145,446 | $144,357 | $747 | $175,648 |
| Total Liabilities | $237,079 | $241,544 | $234,065 | $259,348 | $264,205 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 189,279 | 188,537 | 183,363 | 153,292 | 152,564 |
| Common Shares | 1,886 | 1,883 | 1,833 | 1,533 | 1,524 |
| Retained earnings | -1,947,900 | -1,939,789 | -1,936,835 | -1,919,340 | -1,916,959 |
| Other shareholders' equity | -6 | 4 | 0 | -1 | 1 |
| TOTAL | $9,137 | $14,333 | $14,885 | $-27,258 | $-28,453 |
| Total Liabilities And Equity | $246,216 | $255,877 | $248,950 | $232,090 | $235,752 |